Open Access

Peer-reviewed

Review

Main Article Content

Anubhav Pratap Singhcorresponding author
Yigong Guo
Anika Singh
Wen Xie
Patrick Jiang

Abstract

This review presents the possibilities of oral delivery of insulin. Insulin, being readily destroyed/ transformed by the proteolytic enzymes and first-pass effects in the digestive system, has mainly been administered through injection, such as intravenous injection and transdermal injection. With developments in the material sciences, appropriate encapsulation methodologies have been developed that could be employed to protect insulin from the digestive effects of the human GI system, and thereby have opened a gateway of research exploring the oral route of insulin delivery. One approach is to incorporate insulin into an emulsion with an appropriate oil-phase, which protects the insulin from degradation. Coating with natural or synthetic polymeric materials, or with lipids, followed by size-reduction to 100-1000 nm is applied as another common approaches of insulin encapsulation. Other approaches like liposomes, nanogels, etc. are also being explored. This review gives a summary of methods of preparation as well as in vitro and in vivo bioavailability of insulin through these methods. It is observed that the oral bioavailability of insulin intake has increased from about 0.1% to about 20% for encapsulated insulin.

Keywords
insulin, oral delivery, encapsulation, materials

Article Details

How to Cite
Singh, A., Guo, Y., Singh, A., Xie, W., & Jiang, P. (2019). Developments in encapsulation of insulin: Is oral delivery now possible?. Journal of Pharmaceutical and Biopharmaceutical Research, 1(2), 74-92. https://doi.org/10.25082/JPBR.2019.02.005

References

  1. Nur M and Vasiljevic T. Can natural polymers assist in delivering insulin orally? International Journal of Biological Macromolecules, 2017, 103: 889-901. https://doi.org/10.1016/j.ijbiomac.2017.05.138
  2. McGurk S. Ganong’s Review of Medical Physiology - 23rd edition Kim E Barratt Ganong’s Review of Medical Physiology - 23rd editionet al —McGraw Hill Medical— 726pp—41.99978 0 07160567 00071605673. Nursing Standard, 2010, 24: 30-30. https://doi.org/10.7748/ns.24.20.30.s35
  3. Ramesan RM and Sharma CP. Challenges and advances in nanoparticle-based oral insulin delivery. Expert Review of Medical Devices, 2009, 6: 665-676. https://doi.org/10.1586/erd.09.43
  4. Kitabchi AE, Umpierrez GE, Miles JM, et al. Hyperglycemic crises in adult patients with diabetes. Diabetes Care, 2009, 32: 1335-1343. https://doi.org/10.2337/dc09-9032
  5. Petzold A, SolimenaMand Knoch KP. Mechanisms of Beta Cell Dysfunction Associated With Viral Infection. Current Diabetes Reports, 2015, 15: 857. https://doi.org/10.1007/s11892-015-0654-x
  6. Hu EA, Pan A, Malik V, et al. White rice consumption and risk of type 2 diabetes: meta-analysis and systematic review. Bmj, 2012, 344: e1454-e1454. https://doi.org/10.1136/bmj.e1454
  7. Wild S, Roglic G, Green A, et al. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care, 2004, 27: 1047-1053. https://doi.org/10.2337/diacare.27.5.1047
  8. Ogurtsova K, Guariguata L, Whiting D, et al. Incorporating uncertainty measurement in the International Diabetes Federation Diabetes Atlas methodology for estimating global and national prevalence of diabetes in adults. Archives of Public Health, 2015, 73: 31. https://doi.org/10.1186/2049-3258-73-S1-P31
  9. Damg C, Reis CP and Maincent P. Nanoparticle strategies for the oral delivery of insulin. Expert Opinion on Drug Delivery, 2007, 5: 45-68. https://doi.org/10.1517/17425247.5.1.45
  10. Sonksen P and Sonksen J. Insulin: understanding its action in health and disease. British Journal of Anaesthesia, 2000, 85: 69-79. https://doi.org/10.1093/bja/85.1.69
  11. Heinemann L, Fleming GA, Petrie JR, et al. Insulin Pump Risks and Benefits: A Clinical Appraisal of Pump Safety Standards, Adverse Event Reporting, and Research Needs: A Joint Statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes TechnologyWorking Group. Diabetes Care, 2015, 38:dc150168-722. https://doi.org/10.2337/dc15-0168
  12. Park K, Kwon IC and Park K. Oral protein delivery: Current status and future prospect. Reactive and Functional Polymers, 2011, 71: 280-287. https://doi.org/10.1016/j.reactfunctpolym.2010.10.002
  13. Maianti JP, McFedries A, Foda ZH, et al. Anti-diabetic activity of insulin-degrading enzyme inhibitors mediated by multiple hormones. Nature, 2014, 511: 94-98. https://doi.org/10.1038/nature13297
  14. Zhang H, Huang X, Mi J, et al. Improvement of pulmonary absorptions of poorly absorbable drugs using Gelucire 44/14 as an absorption enhancer. Journal of Pharmacy and Pharmacology, 2014, 66: 1410-1420. https://doi.org/10.1111/jphp.12274
  15. ilek A, elebi N and Tirnaksiz F. Lecithin-Based Microemulsion of a Peptide for Oral Administration: Preparation, Characterization, and Physical Stability of the Formulation. Drug Delivery, 2008, 13: 19-24. https://doi.org/10.1080/10717540500313109
  16. Jain D, Panda AK and Majumdar DK. Eudragit S100 entrapped insulin microspheres for oral delivery. AAPS PharmSciTech, 2005, 6: E100-E107. https://doi.org/10.1208/pt060116
  17. Barbari GR, Dorkoosh F, Amini M, et al. A novel nanoemulsion-based method to produce ultrasmall, waterdispersible nanoparticles from chitosan, surface modified with cell-penetrating peptide for oral delivery of proteins and peptides. International Journal of Nanomedicine, 2017, 12: 3471-3483. https://doi.org/10.2147/IJN.S116063
  18. Giri TK, Choudhary C, Ajazuddin, et al. Prospects of pharmaceuticals and biopharmaceuticals loaded microparticles prepared by double emulsion technique for controlled delivery. Saudi Pharmaceutical Journal, 2013, 21: 125-141. https://doi.org/10.1016/j.jsps.2012.05.009
  19. Mutaliyeva B, Grigoriev D, Madybekova G, et al. Microencapsulation of insulin and its release using w/o/w double emulsion method. Colloids and Surfaces a: Physicochemical and Engineering Aspects, 2017, 521: 147-152. https://doi.org/10.1016/j.colsurfa.2016.10.041
  20. Cournarie F, Savelli MP, Rosilio V, et al. Insulinloaded W/O/W multiple emulsions: comparison of the performances of systems prepared with medium-chaintriglycerides and fish oil. European Journal of Pharmaceutics and Biopharmaceutics, 2004, 58: 477-482. https://doi.org/10.1016/j.ejpb.2004.03.024
  21. Toorisaka E, Hashida M, Kamiya N, et al. An enteric-coated dry emulsion formulation for oral insulin delivery. Journal of Controlled Release, 2005, 107: 91-96. https://doi.org/10.1016/j.jconrel.2005.05.022
  22. Sakloetsakun D, Dnnhaupt S, Barthelmes J, et al. Combining two technologies: multifunctional polymers and selfnanoemulsifying drug delivery system (SNEDDS) for oral insulin administration. International Journal of Biological Macromolecules, 2013, 61: 363-372. https://doi.org/10.1016/j.ijbiomac.2013.08.002
  23. Karamanidou T, Karidi K, Bourganis V, et al. Effective incorporation of insulin in mucus permeating selfnanoemulsifying drug delivery systems. European Journal of Pharmaceutics and Biopharmaceutics, 2015, 97: 223- 229. https://doi.org/10.1016/j.ejpb.2015.04.013
  24. Samad A, Sultana Y and Aqil M. Liposomal Drug Delivery Systems: An Update Review, (n.d.).
  25. Laridi R, Kheadr EE, Benech RO, et al. Liposome encapsulated nisin Z: optimization, stability and release during milk fermentation. International Dairy Journal, 2003, 13: 325- 336. https://doi.org/10.1016/S0958-6946(02)00194-2
  26. Khosravi-Darani K, Pardakhty A, Honarpisheh H, et al. The role of high-resolution imaging in the evaluation of nanosystems for bioactive encapsulation and targeted nanotherapy. Micron, 2007, 38: 804-818. https://doi.org/10.1016/j.micron.2007.06.009
  27. Shehata T, Ogawara KI, Higaki K, et al. Prolongation of residence time of liposome by surface-modification with mixture of hydrophilic polymers. International Journal of Pharmaceutics, 2008, 359: 272-279. https://doi.org/10.1016/j.ijpharm.2008.04.004
  28. Yamauchi M, Tsutsumi K, Abe M, et al. Release of drugs from liposomes varies with particle size. Biological and Pharmaceutical Bulletin, 2007, 30: 963-966. https://doi.org/10.1248/bpb.30.963
  29. Taylor TM, Bruce BD, Weiss J, et al. LISTERIA MONOCYTOGENES AND ESCHERICHIA COLI O157:H7 INHIBITION IN VITRO BY LIPOSOME-ENCAPSULATED NISIN AND ETHYLENE DIAMINETETRAACETIC ACID. Journal of Food Safety, 2008, 28: 183-197. https://doi.org/10.1111/j.1745-4565.2008.00113.x
  30. Kisel MA, Kulik LN, Tsybovsky IS, et al. Liposomes with phosphatidylethanol as a carrier for oral delivery of insulin: studies in the rat. International Journal of Pharmaceutics, 2001, 216: 105-114. https://doi.org/10.1016/S0378-5173(01)00579-8
  31. Simes S, Moreira JN, Fonseca C, et al. On the formulation of pH-sensitive liposomes with long circulation times. Advanced Drug Delivery Reviews, 2004, 56: 947-965. https://doi.org/10.1016/j.addr.2003.10.038
  32. Cui M, Wu W, Hovgaard L, et al. Liposomes containing cholesterol analogues of botanical origin as drug delivery systems to enhance the oral absorption of insulin. International Journal of Pharmaceutics, 2015, 489: 277-284. https://doi.org/10.1016/j.ijpharm.2015.05.006
  33. Zhang N, Ping Q, Huang G, et al. Transport characteristics of wheat germ agglutinin-modified insulin-liposomes and solid lipid nanoparticles in a perfused rat intestinal model. Journal of Nanoscience and Nanotechnology, 2006, 6: 2959-2966. https://doi.org/10.1166/jnn.2006.425
  34. Kim KS, Kwag DS, Hwang HS, et al. Immense Insulin Intestinal Uptake and Lymphatic Transport Using Bile Acid Conjugated Partially Uncapped Liposome. Molecular Pharmaceutics, 2018, 15: 4756-4763. https://doi.org/10.1021/acs.molpharmaceut.8b00708
  35. Deim IT, Gmel B, Deim Z, et al. Oral Administration of Liposomal Insulin. Journal of Nanoscience and Nanotechnology, 2006, 6: 2945-2949. https://doi.org/10.1166/jnn.2006.416
  36. ................
  37. Guo Y and Pratap Singh A. Emerging technologies in buccal and sublingual drug administration. Journal of Drug Delivery Science and Technology, 2019, 52: 440-451. https://doi.org/10.1016/j.jddst.2019.05.014